Market-Moving News for July 28th
Portfolio Pulse from ryanfaloona@benzinga.com
Intel's Q2 EPS of $0.13 beat the estimate of $(0.03), and sales of $12.95B also surpassed the estimate of $12.14B. SIGA announced U.S. government procurement orders worth approximately $138 million for Oral and IV TPOXX. DexCom's Q2 adjusted EPS of $0.34 beat the estimate of $0.23, and sales of $871.30M also beat the estimate of $841.62M.
July 28, 2023 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DexCom's Q2 adjusted earnings and sales beat estimates.
DexCom's better-than-expected Q2 results could boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Intel's Q2 earnings and sales beat estimates.
Intel's better-than-expected Q2 results could boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SIGA announced U.S. government procurement orders worth approximately $138 million.
The significant government procurement order announced by SIGA could increase investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100